Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3

• Published in: PLoS pathogens 2022-09, Vol.18 (9), p.e1010856
• Main Authors: Liu, Pengfei, Zhang, Shengwei, Ma, Jingyi, Jin, Dongning, Qin, Yali, Chen, Mingzhou
• Format: Article
• Language: English
• Subjects: Acetylation; Acetyltransferase; Amino acids; Biology and Life Sciences; Degradation; Dengue fever; Factories; Foot & mouth disease; Genomes; Immunoprecipitation; Inclusion bodies; Infections; Mass spectrometry; Mass spectroscopy; Parainfluenza; Peptides; Physical Sciences; Plasmids; Proteins; Replication; Research and Analysis Methods; RNA polymerase; Scientific imaging; Severe acute respiratory syndrome coronavirus 2; Transcription; Tubulin; Vimentin; Viral infections; Viruses
• ISSN: 1553-7374; 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1010856

We previously found that, among human parainfluenza virus type 3 (HPIV3) proteins, the interaction of nucleoprotein (N) and phosphoprotein (P) provides the minimal requirement for the formation of cytoplasmic inclusion bodies (IBs), which are sites of RNA synthesis, and that acetylated α-tubulin enhances IB fusion and viral replication. In this study, using immunoprecipitation and mass spectrometry assays, we determined that vimentin (VIM) specifically interacted with the N–P complex of HPIV3, and that the head domain of VIM was responsible for this interaction, contributing to the inhibition of IB fusion and viral replication. Furthermore, we found that VIM promoted the degradation of α-tubulin acetyltransferase 1 (α-TAT1), through its head region, thereby inhibiting the acetylation of α-tubulin, IB fusion, and viral replication. In addition, we identified a 20-amino-acid peptide derived from the head region of VIM that participated in the interaction with the N–P complex and inhibited viral replication. Our findings suggest that VIM inhibits the formation of HPIV3 IBs by downregulating α-tubulin acetylation via enhancing the degradation of α-TAT1. Our work sheds light on a new mechanism by which VIM suppresses HPIV3 replication.